These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Use of new beta-lactams in respiratory infections. Grassi C Ala J Med Sci; 1985 Apr; 22(2):189-93. PubMed ID: 4003705 [No Abstract] [Full Text] [Related]
5. The 50th anniversary of the discovery of 6-aminopenicillanic acid (6-APA). Rolinson GN; Geddes AM Int J Antimicrob Agents; 2007 Jan; 29(1):3-8. PubMed ID: 17137753 [TBL] [Abstract][Full Text] [Related]
6. What to do about the new penicillins and cephalosporins. Kunin CM Ohio State Med J; 1984 Apr; 80(4):315-6. PubMed ID: 6717885 [No Abstract] [Full Text] [Related]
7. [General principles in the use of antimicrobials]. Reyes PA; Biro CE Arch Inst Cardiol Mex; 1970; 40(1):74-89. PubMed ID: 5433062 [No Abstract] [Full Text] [Related]
8. [Five-year analysis of extrahospital consumption of betalactams in Spain]. Calvo Plaza MI; Moreno Ubeda RM; Dominguez Rojas VD; Prieto Prieto JP; Rev Esp Quimioter; 2000 Dec; 13(4):417-24. PubMed ID: 11498711 [TBL] [Abstract][Full Text] [Related]
9. Beta-lactam antibiotics: newer formulations and newer agents. Martin SI; Kaye KM Infect Dis Clin North Am; 2004 Sep; 18(3):603-19, ix. PubMed ID: 15308278 [TBL] [Abstract][Full Text] [Related]
10. [Use of semisynthetic penicillins and cephalosporins in trauma and orthopedic patients]. Mel'nikova VM; Gladshteĭn AI Antibiotiki; 1984 Aug; 29(8):614-5. PubMed ID: 6486757 [TBL] [Abstract][Full Text] [Related]
11. [Current therapies 1990-1995 in infectious diseases]. Scheen AJ Rev Med Liege; 1995 Oct; 50(10):413-7. PubMed ID: 7491439 [No Abstract] [Full Text] [Related]
12. beta-Lactams without a suicide inhibitor. Giamarellou H Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():194-7. PubMed ID: 18154547 [TBL] [Abstract][Full Text] [Related]
13. [Situation and choice of antimicrobial agents with effects on the so-called "non-specific" respiratory infections]. Mangiarotti P Arch Monaldi Mal Torace; 1989; 44(4-6):743-52. PubMed ID: 2577791 [No Abstract] [Full Text] [Related]
14. Criteria for selection of antibiotics in empiric therapy of presumed gram negative infection. Betts RF Ration Drug Ther; 1981 Apr; 15(4):1-5. PubMed ID: 7347853 [No Abstract] [Full Text] [Related]
15. The use of antimicrobial agents in patients with hepatic and renal dysfunction. Howard PH; Raebel M; Hurley DL Surg Clin North Am; 1982 Apr; 62(2):333-40. PubMed ID: 7071698 [No Abstract] [Full Text] [Related]
16. Antibacterial management of infection due to gram-negative bacilli. 3. Use of ampicillin, the cephalosporins, spectinomycin, and chemotherapy. Martin WJ Minn Med; 1966 Jul; 49(7):1161-7. PubMed ID: 4223094 [No Abstract] [Full Text] [Related]
17. Benefits of negative penicillin skin test results persist during subsequent hospital admissions. Perencevich EN; Weller PF; Samore MH; Harris AD Clin Infect Dis; 2001 Jan; 32(2):317-9. PubMed ID: 11170927 [TBL] [Abstract][Full Text] [Related]
18. [New penicillins and cephalosporins]. Lopes HV AMB Rev Assoc Med Bras; 1984; 30(11-12):215-24. PubMed ID: 6398883 [No Abstract] [Full Text] [Related]
19. The evidence base for cephalosporin superiority over penicillin in streptococcal pharyngitis. Casey JR; Pichichero ME Diagn Microbiol Infect Dis; 2007 Mar; 57(3 Suppl):39S-45S. PubMed ID: 17292576 [TBL] [Abstract][Full Text] [Related]
20. The choice of systemic antimicrobial drugs. Med Lett Drugs Ther; 1968 Oct; 10(20):77-84. PubMed ID: 5731799 [No Abstract] [Full Text] [Related] [Next] [New Search]